Novartis India Limited operates as a healthcare company in India. It offers therapeutic products in the areas of bone and pain products under the Voveran brand; transplantation immunology products under the Simulect, Certican, Sandimmun, Neoral, and Myfortic brands; and neurosciences products under the Tegrital and Exelon brands. The company was incorporated in 1947 and is based in Mumbai, India. Novartis India Limited is a subsidiary of Novartis AG.
Stock data | 2024 | Change |
---|---|---|
Price | $12.81 | N/A |
Market Cap | $316.32M | N/A |
Shares Outstanding | 24.69M | N/A |
Employees | 67.00 | N/A |